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The hepatitis C virus (HCV) p7 ion channel and non-structural protein 2 (NS2) are both required
for efficient assembly and release of nascent virions, yet precisely how these proteins are able to
influence this process is unclear. Here, we provide both biochemical and cell biological evidence
for a functional interaction between p7 and NS2. We demonstrate that in the context of a
genotype 1b subgenomic replicon the localization of NS2 is affected by the presence of an
upstream p7 with its cognate signal peptide derived from the C terminus of E2 (SPp7).
Immunofluorescence analysis revealed that the presence of SPp7 resulted in the targeting of NS2
to sites closely associated with viral replication complexes. In addition, biochemical analysis
demonstrated that, in the presence of SPp7, a significant proportion of NS2 was found in a
detergent (Triton X-100)-insoluble fraction, which also contained a marker of detergent resistant
rafts. In contrast, in replicons lacking p7, NS2 was entirely detergent soluble and the altered
localization was lost. Furthermore, we found that serine 168 within NS2 was required for its
localization adjacent to replication complexes, but not for its accumulation in the detergent-
insoluble fraction. NS2 physically interacted with NS5A and this interaction was dependent on
both p7 and serine 168 within NS2. Mutational and pharmacological analyses demonstrated that
these effects were not a consequence of p7 ion channel function, suggesting that p7 possesses
an alternative function that may influence the coordination of virus genome replication and particle
assembly.
INTRODUCTION
Hepatitis C virus (HCV) infects over 170 million
individuals and is a major cause of chronic liver disease,
resulting in cirrhosis and hepatocellular carcinoma
(Lavanchy, 1999). Current therapies based on a combina-
tion of pegylated alpha interferon and ribavirin are
ineffective in around 50% of the cases due to the high
prevalence of genotype 1 resistant strains. This has driven
intensive research for the development of virus-specific
therapies. Subgenomic replicon (SGR)-based approaches
have expedited the development of compounds targeting
virus genome replication, but it is only recently, following
the development of an infectious culture system for HCV
based on the genotype 2a isolate, JFH-1 (Wakita et al.,
2005), that it has become possible to study the processes
involved in virus assembly.
HCV is a member of the genus Hepacivirus of the family
Flaviviridae. It possesses a positive-sense RNA genome
of ~9.6 kb and forms an enveloped particle ~60 nm in
diameter. The genome contains a single ORF and the
translation product is cleaved into 10 mature products by
both host and viral proteases. The core (C) and envelope
(E1/E2) proteins together with the genomic RNA comprise
the infectious virion, whereas the non-structural (NS)
proteins NS3–NS5B are both necessary and sufficient for
viral genome replication and form membrane associated
replication complexes in infected cells (Moradpour et al.,
2007). The two remaining proteins, p7 and NS2, are dis-
pensable for HCV RNA replication, but have been shown
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to play a critical role in the production of infectious virus
particles (Jones et al., 2007; Steinmann et al., 2007a).
p7 (63 aa) comprises two trans-membrane domains and a
conserved basic cytosolic loop (Carre`re-Kremer et al., 2002;
Lin et al., 1994). It possesses ion channel activity in vitro
(Griffin et al., 2003; Pavlovic´ et al., 2003; Premkumar et al.,
2004) and forms hexa- or heptameric channels (Clarke
et al., 2006; Luik et al., 2009), which are blocked by several
classes of small molecules (Griffin, 2010). These inhibitors
block virion release in cell culture, strongly implicating a
functional requirement for ion channel activity during
this process (Griffin et al., 2008; Steinmann et al., 2007b).
Deletion of p7 or specific point mutations abrogate HCV
particle release in culture (Jones et al., 2007; Steinmann
et al., 2007a), yet the specificity of these mutations regard-
ing ion channel activity or an as-yet undefined alternative
role for p7 has not been established. We recently demon-
strated that p7 proton channel function is directly
responsible for the enhancement of infectious virion pro-
duction (Wozniak et al., 2010). Interestingly, p7 point
mutants can be rescued by the vATPase inhibitor,
bafilomycin A, or by exogenous expression of the influenza
M2 proton channel, whereas this is not the case for p7
deletants, suggesting that non-ion channel functions of p7
are disrupted (Wozniak et al., 2010; Brohm et al., 2009).
NS2 possesses a highly hydrophobic N-terminal region
(residues 1–93), proposed to contain three trans-mem-
brane helices, as well as a C-terminal cytosolic auto-
protease domain (residues 94–217) that functions to cleave
the NS2–3 precursor (Grakoui et al., 1993). Although NS2
is not required for genome replication, if present (in either
NS2 containing SGR or full-length virus) replication is
dependent on NS2–3 cleavage (Jones et al., 2007; Welbourn
et al., 2005). This is probably due to a requirement for
mature NS3, as artificial separation of NS2–3 results in
replication-competent genomes and renders HCV inde-
pendent of mutations that disrupt the NS2 protease active
site (Jones et al., 2007). Nevertheless, deletion of NS2, and
specifically its C terminus, causes a profound defect in
HCV particle production providing clear evidence of a role
for mature NS2 in assembly separate to its auto-protease
function.
There is increasing genetic and biochemical evidence
for cooperation between p7 and NS2 during assembly.
Chimeric HCV genomes, where structural proteins from
other genotypes are joined to the JFH-1 non-structural
region, only efficiently produce particles when the N
terminus of NS2 originates from the same sequence as the
structural proteins (Pietschmann et al., 2006). Similarly, p7
chimeras were only seen to replicate in chimpanzees when
the p7 termini remained parental in origin (Sakai et al.,
2003). Several adaptive mutations in both p7 and NS2 have
also been described that independently enhance particle
production and/or rescue mutations in other regions of the
genome (Russell et al., 2008; Yi et al., 2007). Recently, using
a recombinant virus expressing a p7–GFP fusion separated
from NS2 by an IRES, a physical interaction between p7
and NS2 was demonstrated (Ma et al., 2011). NS2 has
also been proposed to interact with other non-structural
proteins, providing a potential link between replication
and assembly (Dimitrova et al., 2003; Flajolet et al., 2000).
Furthermore, p7 and NS2 are generated by an inefficient
signallase-mediated cleavage of the E2–p7–NS2 precursor,
suggesting an advantage in regulating the amount of
mature protein in the cell (Carre`re-Kremer et al., 2004).
The C-terminal region of p7 has also been proposed to act
as a signal peptide for NS2, although both p7 and NS2 are
able to associate with endoplasmic reticulum (ER) mem-
branes independently of an upstream signal sequence
(Carre`re-Kremer et al., 2002; Griffin et al., 2005; Santolini
et al., 1995).
Here, we provide evidence for p7-mediated targeting of NS2
to a compartment closely associated with HCV replica-
tion complexes, concomitantly causing it to accumulate in
raft-like, detergent-insoluble membranes. This effect is
independent of p7 ion channel function and could provide
a means by which these proteins link HCV replication with
the assembly pathway.
RESULTS
Characterization of SGRs containing NS2 and p7
sequences
As discussed, evidence points to an interdependence
between p7 and NS2 during HCV assembly. As deletions
and/or inactivating point mutations within p7 render full-
length JFH-1 genomes non-infectious, we sought to
establish an alternative system to analyse the relationship
between p7 and NS2. To this end we modified the culture-
adapted, genotype 1b, SGR (FK5.1) (Krieger et al., 2001) by
adding either NS2 alone (SGR-NS2), or NS2 together with
p7 and its E2-derived cognate signal peptide (SGR-SPp7)
(Fig. 1a). Both replicons were viable and, as previously
demonstrated, addition of NS2 resulted in reduced RNA
replication efficiency (Lohmann et al., 1999), measured by
both colony formation (Fig. 1a) and luciferase activity (Fig.
1b). The addition of SPp7 gave a further modest reduction
in replication efficiency. This may be due to an effect of
SPp7 on the stability of the non-structural proteins (Fig.
1c). Intriguingly, replicons containing either p7 in the
absence of its cognate signal peptide, or solely the C-
terminal helix (comprising the signal peptide required for
cleavage between p7 and NS2), were not viable, although
this was not due to defects in translation or polyprotein
processing (data not shown). We conclude that, at least in
the context of a genotype 1b replicon, the presence of an
upstream signal peptide is likely to be essential for correct
membrane insertion of p7 and subsequent membrane
topology of NS2. However, it should be noted that in the
J6/JFH1 chimeric virus p7 functionality is retained when
preceded by an IRES (E2-IRES-p7 virus) (Jones et al.,
2007). Thus, the presence of intact envelope glycoproteins
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may also facilitate correct membrane insertion of p7 and
NS2.
The presence of p7 results in an altered
distribution of NS2
To gain insight into the potential effects of p7 on NS2
function we established stable Huh7.5 cell lines harbouring
SGR-NS2 and SGR-SPp7. The SGR-NS2 harbouring cells
expressed the HCV non-structural proteins to similar levels
as the FK5.1 (SGR-NS3) cells (Fig. 1c). However, consistent
with the differences in replication efficiency (Fig. 1b), in
the SGR-SPp7 harbouring cells, non-structural protein
expression was lower. Of note, levels of neomycin phos-
photransferase were equivalent, suggesting that SPp7 was
not having a global inhibitory effect on protein translation
from the bicistronic replicon RNA. These observations
suggested that p7 was indeed influencing the function of
the non-structural proteins, so we therefore examined
the subcellular localization of NS2, NS3 and NS5A by
immunofluorescence. In cells harbouring SGR-NS2, both
NS2 and NS5A exhibited a punctate cytoplasmic local-
ization, but did not colocalize (Fig. 2a). Contrastingly, in
cells harbouring SGR-SPp7, NS2 and NS5A were less widely
dispersed within the cytoplasm and exhibited a high degree
of colocalization, marked by a close apposition and overlap
of the NS2 and NS5A signals. This difference was also
observed when NS2 and NS3 distribution were analysed – in
the SGR-NS2-harbouring cells there was again a lack of
colocalization between NS2 and NS3, whilst in the SGR-
SPp7-harbouring cells they were less widely dispersed and
significantly colocalized (Fig. 2b). These data are consistent
with the hypothesis that the presence of p7 directs NS2 to a
location proximal to sites of viral genome replication.
We also conducted a biochemical analysis of the distri-
bution of NS2 by lysis in ice-cold Triton X-100 (TX-100)
followed by centrifugal separation into detergent-soluble
(S) or -insoluble (I) fractions. In the context of the SGR-
NS2, NS2 was found solely in the soluble fraction (Fig. 2c,
lanes 5 and 6); in SGR-SPp7, however, NS2 was found in
both the soluble and insoluble fractions (Fig. 2c, lanes 7
and 8). Western blotting for cellular markers showed that
Fig. 1. Generation and characterization of
p7-containing SGR. (a) Schematic of the
constructs produced. Residue numbers are
indicated. RNA was generated for each con-
struct and transfected into Huh7.5 cells that
were placed under G418 selection for 2 weeks.
Colonies were stained with Coomassie brilliant
blue and counted. Mean number of colonies±
SD is indicated (n53). (b) Huh7.5 cells were
electroporated with the indicated SGR RNAs
and harvested at 4 and 72 h post-transfection
(p.t.) for the determination of luciferase activity.
SD are indicated (n53). RLU, Relative light units.
(c) Lysates from cells harbouring the indicated
SGR were separated by 12% SDS-PAGE and
probed by Western blotting for the indicated
proteins.
HCV p7 influences NS2 targeting
http://vir.sgmjournals.org 821
the detergent-insoluble fraction contained raft-like mem-
branes as indicated by the presence of Flotillin-1, as well as
nuclear material (histone H1) (Fig. 2c). As NS2 could be
clearly shown by immunofluorescence to be absent from
the nucleus (Fig. 2a), we conclude that p7 targets at least a
proportion of NS2 to a detergent-insoluble fraction. The
detergent-soluble fraction contained ER and mitochon-
dria-derived membranes (indicated by calreticulin and
cytochrome c, respectively) as well as cytosolic proteins
(GAPDH). Contrary to previous reports (Gao et al., 2004;
Shi et al., 2003), the detergent-insoluble fraction did not
contain NS5A (Fig. 2c). This further supports the con-
clusion that in the presence of p7, NS2 is not being
incorporated into replication complexes per se, but rather
is being targeted to a location adjacent to these sites of viral
genome replication.
Fig. 2. Localization of NS2 in cells harbouring SGRs. SGR harbouring cells were fixed and stained for NS5A (a), or NS3 (b),
and NS2, and nuclei were stained with Hoechst 33342. An enlarged area is shown to the right of the merged image, indicated
by a box. Bars, 10 mm. (c) SGR-harbouring cells were harvested, lysed and separated into detergent-insoluble and -soluble
fractions. Fractions were separated by 12% SDS-PAGE and probed by Western blotting. The panel on the right shows the
distribution of the indicated cellular proteins in the two fractions. I, Detergent-insoluble fraction; S, detergent-soluble fraction.
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Serine 168 of NS2 is required for the p7-mediated
alteration in NS2 distribution, but not for the
association with the detergent-insoluble fraction
Previous reports have implicated a role for serine 168
within NS2 in virus assembly as a mutation at this residue
impairs virion production (Jirasko et al., 2008; Yi et al.,
2009), and this residue can be phosphorylated by casein
kinase 2 (CK2), leading to proteosomal degradation (Franck
et al., 2005). As our data suggested that p7 affected the
trafficking of NS2, we therefore asked whether serine 168
also played a role in this aspect of NS2 function. SGR-
NS2(S168A) and SGR-SPp7(S168A) replicons were replica-
tion competent (data not shown), and could establish
stable, replicon harbouring cell lines. In cells harbouring
SGR-NS2(S168A), the distribution of NS2 as observed by
fractionation (Fig. 3a) or immunofluorescence (Fig. 3b,
compare to Fig. 2a, top panel) was unchanged. However,
fractionation analysis revealed that in the context of SGR-
SPp7, S168A had no effect on the presence of NS2 in the
detergent-insoluble fraction (Fig. 3a, compare lanes 7 and 8,
and 9 and 10). In contrast, in the context of SGR-SPp7, the
S168A mutation resulted in a drastic alteration in the
distribution of NS2 such that it closely resembled SGR-NS2
with very little colocalization between NS2 and NS5A (Fig.
3c). These data suggest that serine 168 is not required for the
targeting of NS2 to the detergent-insoluble fraction, but it
does play a role in the p7-mediated localization of NS2 to
sites proximal to NS5A and replication complexes seen in
SGR-SPp7 (Fig. 3c).
These data also implied that serine 168 might be involved
in a physical interaction between NS2 and components of
the replication complexes. To test this we performed a
coimmunoprecipitation analysis. As NS5A is a key com-
ponent of the replication complex and also plays a major
role in assembly (Hughes et al., 2009; Masaki et al., 2008;
Tellinghuisen et al., 2008), we immunoprecipitated cell
lysates with an NS5A antibody and analysed the pre-
cipitates by Western blot. NS2 coprecipitated with NS5A
from lysates of SGR-SPp7 harbouring cells (Fig. 3d, lane 3),
but not from either SGR-NS2 or SGR-SPp7(S168A) lysates
(lanes 2 and 4). Furthermore, when lysates were immuno-
precipitated with an NS2 antibody, NS5A was only found
to precipitate with NS2 in the context of SGR-SPp7 and
was absent in the S168A mutant (Fig. 3d, right hand panel).
These data are consistent with a direct interaction between
NS2 and NS5A, which requires both p7 and serine 168
within NS2. However, we cannot rule out the possibility
that this interaction is mediated via additional interactions
between NS2, NS5A and other viral or cellular proteins.
The presence of NS2 in the detergent-insoluble
fraction is independent of p7 ion channel activity
The ion channel activity of p7 has been shown to be required
during virus assembly (Jones et al., 2007; Steinmann et al.,
2007a), and it has recently been shown to be critical in
protecting intracellular virions from acid pH (Wozniak,
et al., 2010). We therefore sought to investigate whether the
altered distribution of NS2 required the ion channel
function of p7. To this end we disrupted p7 function by
introducing specific point mutations into SGR-SPp7, which
have previously been demonstrated to disrupt p7 ion
channel activity in vitro (StGelais et al., 2009) as well as in
mammalian cells (Griffin et al., 2004). Mutation of the basic
charges on the p7 cytosolic loop (K33A/R35A) has been
shown to disrupt both p7 function and secretion of infec-
tious virus (Steinmann et al., 2007a), yet our recent data
indicate that it also disrupts polyprotein processing and
dramatically reduces the abundance of p7 and NS2 (S.
Griffin, data not shown), which may be linked to inefficient
membrane insertion observed for this mutant in vitro
(StGelais et al., 2009). We therefore also introduced two
alternative mutations; H17A and G39A, which do not cause
such defects in mammalian cells yet abrogate p7 activity in
vitro without affecting membrane insertion (StGelais et al.,
2009). We established stable, replicon harbouring cell lines
for each of these mutants and assessed the distribution of
NS2 both by fractionation and fluorescence as described
above. The effects of mutating the basic loop [SGR-
SPp7(KR)] were immediately apparent, with NS2 abundance
being reduced below detectable levels by Western blot
(Fig. 4a: lanes 5 and 6, Fig. 4c). Consistent with the low
abundance of NS2 in Western blots, immunofluorescence
revealed an SGR-NS2 type staining pattern for NS5A in cells
harbouring SGR-SPp7(KR) and NS2 fluorescence was barely
detectable above background (Fig. 4c). The other mutations,
however, behaved as the parental SGR-SPp7; NS2 being
present in the detergent-insoluble fraction and localizing
adjacent to NS5A in bright foci (Fig. 4a: lanes 7–10, Fig. 4c).
Interestingly, G39A resulted in a reduction in the amount of
NS2 in the insoluble fraction – this is consistent with its
more profound effect on ion channel activity (StGelais et al.,
2009), perhaps reflective of a more dramatic effect on p7
structure and ion channel-independent functions. Previous
in vitro studies showed that the H17A defect could be
partially overcome by increasing the concentration of
purified p7 protein, whereas for G39A this was not the case
(StGelais et al., 2009). As an additional control, SGR-SPp7
harbouring cells were treated with 50 mM rimantadine,
which inhibits p7 ion channel activity both in vitro and in
cell culture (Griffin et al., 2008; StGelais et al., 2007;
Wozniak et al., 2010); again this did not affect the
localization of NS2 (Fig. 4b: lanes 9–12, Fig. 4c). These data
confirm that the altered distribution of NS2 by p7 does not
require the ion channel activity of the latter protein.
The p7-mediated distribution of NS2 is observed
in the context of the full-length virus
To confirm that our findings were not restricted to the
genotype 1b Con1 isolate, the localization of NS2 was
examined in the context of the genotype 2a JFH-1
sequence. SGR-JFH-1-NS2 and SGR-JFH-1-SPp7 were
produced in an analogous fashion to those described for
Con1. Huh7.5 cells stably harbouring these SGRs, or
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transiently transfected with the full-length infectious JFH-
1, were fractionated as previously described. Whereas in the
context of full-length infectious JFH-1, NS2 was seen in
both the detergent-insoluble and -soluble fractions (Fig. 5a,
lanes 3 and 4), in the SGR-JFH-1-NS2 harbouring cells
NS2 was found only in the detergent-soluble fraction (lanes
Fig. 3. Role of NS2 serine 168 in the p7-mediated altered distribution of NS2. (a) Huh7.5 and SGR harbouring cells were
harvested, lysed and separated into detergent-insoluble and -soluble fractions. These were separated by 12% SDS-PAGE and
probed by Western blotting. I, Detergent-insoluble fraction; S, detergent-soluble fraction. (b) SGR-NS2(S168A) and (c) SGR-
SPp7(S168A) harbouring cells were fixed and probed for NS5A and NS2, and nuclei were stained with Hoechst 33342. An
enlarged area is shown to the right of the merged image, indicated by a box. Bars, 10 mm. (d) SGR harbouring cells were lysed,
then immunoprecipitated with either a sheep anti-NS5A serum (left panel), or a rabbit anti-NS2 serum (right panel), and the inputs
and eluates probed for NS5A and NS2 using the indicated antibodies. Input lysates were probed for GAPDH as a loading control.
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7 and 8), even upon overexposure of the Western blot
(data not shown). We were unable to detect NS2 in the
SGR-JFH-1-SPp7 harbouring cells as the anti-NS2 serum
exhibited reduced sensitivity for genotype 2a NS2 in
Western blot, compared with the 1b protein. Additionally,
it was not possible to detect NS2 in any of the JFH-1 SGR
harbouring cells by immunofluorescence. However, the
higher viral protein expression levels in cells transfected
with full-length JFH-1 RNA (Fig. 5a) permitted direct
detection of NS2 by immunofluorescence (Fig. 5b), and
we again confirmed that it localized adjacent to NS5A.
The high level of virus replication also permitted the use
of the J2 antibody raised to dsRNA. As shown in Fig. 5(b),
similar to that observed previously (Targett-Adams et al.,
2008), NS5A showed a significant degree of colocalization
with dsRNA. This was less apparent for NS2, although
NS2 foci were predominantly observed adjacent to sites
containing dsRNA (Fig. 5b). This is again consistent with
the targeting of NS2 to sites adjacent to replication
complexes.
Targeting of NS2 does not require the p7-NS2
precursor
Although the targeting of NS2 appeared p7-dependent, it
was not clear whether this occurred prior to, or follow-
ing, cleavage of the p7-NS2 precursor. It was therefore
necessary to demonstrate whether this precursor mediated
NS2 targeting, or whether it occurred via a protein–protein
interaction between the mature proteins. We addressed this
question by transfecting Huh7.5 cells with RNAs derived
from modified chimeric J6/JFH-1-derived genomes in
which p7 and NS2 were separated by an IRES [J6/JFH-
1(p7-I-NS2)] (Jones et al., 2007). Consistent with the
recent observation that NS2 will function in trans during
HCV particle assembly (Yi et al., 2009), NS2 was targeted
to the detergent-insoluble fraction in cells transfected with
p7-I-NS2 RNA, as well those transfected with an RNA in
which NS2 and NS3 were separated by an IRES (NS2-I-
NS3) (Fig. 5c). The data from these experiments confirm
that p7 can mediate the altered distribution of NS2 in trans,
and the uncleaved p7-NS2 precursor is not required for
this observed effect.
DISCUSSION
A key unresolved question in HCV biology is how the
processes of genome replication and assembly are coordi-
nated and linked, such that infectious virus particles can be
generated. In this context, HCV mutants lacking p7 or NS2
are able to undergo genome replication but cannot pro-
duce new virions (Jones et al., 2007; Steinmann et al.,
2007a); it is likely therefore that both proteins function at
the interface between genome replication and packaging.
Our data are consistent with the hypothesis that p7 targets
NS2 to sites adjacent to replication complexes where it
interacts with NS5A and potentially other replication com-
plex components, thereby facilitating the coordination of
genome replication and virion assembly.
As well as a redistribution of NS2, biochemical character-
ization revealed that the presence of the upstream SPp7
sequence resulted in the accumulation of NS2 in a
detergent-insoluble fraction. It is unclear whether the dis-
tribution of NS2 into detergent-insoluble and -soluble
fractions in SGR-SPp7 harbouring cells represents two sites
of localization for NS2 or a single site with partial
resistance to detergent solubilization. Immunofluorescence
data indicate that the latter case is more likely, as in this
context the vast majority of NS2 localizes adjacent to
replication complexes, i.e. is localized to a single compart-
ment. However, data obtained in the context of the S168A
mutation are consistent with the suggestion that the popula-
tion of NS2 presented in the detergent-insoluble fraction is
distinct from that colocalized with replication complexes.
Specifically, the accumulation of NS2 in the detergent-
insoluble fraction was independent of serine 168, whereas
colocalization and interaction with NS5A were dependent on
this residue (Fig. 3). The identification of an NS5A mutant
that abrogated the NS2–NS5A interaction might help to
reconcile this question; however, our data are in agreement
with previous work (Franck et al., 2005; Jirasko et al., 2008; Yi
et al., 2009), implicating a critical role for serine 168 in the
biology of NS2. Intriguingly, cells harbouring SGR-SPp7
exhibited reduced levels of NS5A (and NS3 and NS5B)
compared with those harbouring FK5.1 [SGR(NS3-5B)] or
SGR-NS2 (Fig. 1c), but the NS5A levels were restored by the
S168Amutation (Fig. 3c). This observation suggests that NS2
interacts with NS5A and might ultimately target NS5A for
degradation in the absence of ongoing virion morphogenesis.
Our data are also consistent with the observation (Yi et al.,
2009) that the assembly defects associated with the NS2
S168A mutation can be compensated for by mutations in
NS5A. As serine 168 has been shown to be phosphorylated by
CK2 in vitro, our data suggest that phosphorylation of NS2
may be an important regulatory feature in the ability of NS2
to mediate the interface between genome replication and
particle assembly (Franck et al., 2005; Jirasko et al., 2008; Yi
Fig. 4. p7 ion channel activity is not required for the altered distribution of NS2. (a) Cells harbouring SGR-SPp7 with mutations
in p7 were harvested, lysed and separated into detergent-insoluble and -soluble fractions. Fractions were separated by 12%
SDS-PAGE and probed by Western blotting. (b) Cells were incubated overnight in 50 mM rimantadine then treated as in (a).
RIM, Rimantadine; I, detergent-insoluble fraction; S, detergent-soluble fraction. (c) Cells harbouring SGR-SPp7 with the
indicated mutations in p7, or SGR-SPp7 wild-type cells treated with rimantadine, were fixed and probed for NS5A and NS2.
Nuclei were stained with Hoechst 33342. An enlarged area is shown to the right of the merged image, indicated by a box. Bars,
10 mm.
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Fig. 5. Localization of NS2 in cells infected with JFH-1 or harbouring a JFH-1-derived SGR. (a) Huh7.5 cells transfected with
full-length JFH-1 RNA or stably harbouring SGR-JFH-1(NS2-5B) were harvested, fractionated into detergent-insoluble and
-soluble fractions, separated by 12% SDS-PAGE and probed for NS2 or GAPDH. (b) Huh7.5 cells transfected with full-length
JFH-1 RNA were fixed at 48 h p.t. in 4% paraformaldehyde and permeabilized with 0.2% TX-100 in PBS, prior to staining with
antibodies to NS5A, NS2 or dsRNA as indicated. Nuclei were stained with Hoechst 33342. An enlarged area is shown to the
right of the merged image, indicated by a box. Bars, 10 mm. (c) Cells were electroporated with J6/JFH chimeric RNAs, wild-type
or bicistronic with an IRES between p7 and NS2 (P7-I-NS2) or NS2 and NS3 (NS2-I-NS3) (Jones et al., 2007). Cells were
harvested, lysed, separated into detergent-insoluble and -soluble fractions and probed by Western blotting. I, Detergent-
insoluble fraction; S, detergent-soluble fraction.
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et al., 2009). It will be of great interest to establish the effect of
p7 on the phosphorylation state of NS2.
The observation that p7 directs NS2 to a site adjacent to
replication complexes also provides a potential solution to
a paradox of HCV biology, namely that membrane-bound
RNA replication complexes isolated from NS3-5B replicon
cells are resistant to both nuclease and protease digestion in
vitro (Aizaki et al., 2004; Yang et al., 2004). How then do
nascent genomes get exported from this compartment in
order to undergo assembly into virus particles? It may be
that NS2 provides such a mechanism by positioning at an
exit site of the replication compartment – explaining both
the juxtaposition of NS2 and the replication complexes in
SGR-SPp7 harbouring cells, and the previously observed
requirement for NS2 in the production of infectious virus
particles (Jones et al., 2007). Implicit in this hypothesis
would be interactions between NS2 and both the structural
and non-structural proteins. Consistent with this, it has
recently been shown that NS2 interacts with E1, E2, p7,
NS3 and NS5A (Ma et al., 2011) and it is likely therefore
that NS2 functions to mediate the interaction between the
replication complex and the structural proteins, perhaps
acting in concert with the recently defined interaction
between NS5A and core (Masaki et al., 2008). Alternatively,
NS2 may function in the release of RNA from the repli-
cation complex and allow its encapsidation into nascent
HCV particles. As well as the direct physical interaction,
there is genetic evidence for a p7–NS2 interaction from
studies of chimeric HCV genomes based on JFH-1. These
viruses only produce infectious particles when the N-
terminal trans-membrane helix of NS2 is derived from the
same isolate as the other structural proteins (including p7)
(Pietschmann et al., 2006). In addition, our finding that
complementing proton channel activity is insufficient to
rescue p7 deletants, yet efficiently restores particle pro-
duction to point mutants confirms that a p7-specific
protein–protein interaction is likely to be required for an
early stage of virion morphogenesis (Wozniak et al., 2010).
The data herein provides additional support for an interac-
tion between p7 and NS2 and furthermore imply that the
resultant redistribution of NS2 into close apposition with
replication complexes is a critical event during the assembly
of infectious virus particles.
METHODS
HCV replicon constructs. An RsrII–BsrGI fragment containing the
EMCV IRES and the 59 end of the NS3 coding region was subcloned from
the culture-adapted Con1 NS3–NS5B SGR, FK5.1 (Krieger et al., 2001)
into Litmus38. Within this subclone a unique NcoI site incorporating the
AUG of the HCV ORF was used in conjunction with BsrGI to introduce
additional sequences to the N terminus of NS3. HCV-derived sequences
were amplified from the genotype 1b Con1 infectious clone using Pfu
polymerase (Stratagene). PmeI–BsrGI fragments of the subclone were
transferred back into the FK5.1 backbone. Constructs carrying firefly
luciferase were generated by excising the neomycin phosphotransferase
coding AscI–PmeI fragment and replacing it with the corresponding
luciferase coding fragment from pFK5.1luc (Krieger et al., 2001).
To generate JFH-1-derived SGRs, a subclone of the JFH-1 SGR (Kato
et al., 2003) was created by cloning the PmeI–SpeI fragment into a
modified Litmus28 vector in which the NcoI site was replaced with
PmeI (Litmus28P). This was linearized with NcoI, blunted with mung
bean nuclease (New England Biolabs) then digested with KasI. The
NS2 coding region of JFH-1 was amplified by PCR using a forward
primer containing a start codon and a reverse primer extending to the
KasI site in NS3, then digested with KasI and ligated into the
subclone. The PmeI–ClaI fragment of the subclone was replaced in
the JFH-1 SGR creating SGR-JFH-1-NS2.
Mammalian cell culture. Huh7.5 cells were cultured in Dulbecco’s
modified Eagle’s medium, supplemented with 10% (v/v) FBS, 100 U
penicillin ml21, 100 mg streptomycin ml21, 2 mM L-glutamine and
non-essential amino acids (Gibco) at 37 uC, 5% CO2, in a humidified
incubator. Stable cell lines weremaintained with 500 mg G418 (Melford)
ml21. Where indicated rimantadine (provided by GlaxoSmithKline)
was prepared as a stock solution (40 mM) in DMSO.
Transfection of Huh7.5 cells. Templates for transcription were
prepared by linearization with either ScaI (FK5.1) or XbaI (JFH-1),
the latter were also mung bean nuclease treated. RNA was transcribed
using Ribomax Express (Promega). RNA was transfected into cells as
described previously (Lohmann et al., 1999). Briefly, Huh7.5 cells
were trypsinized, washed twice in ice-cold PBS then resuspended
in ice-cold PBS at 1 or 26107 cells ml21 for replicon or virus,
respectively. RNA (1 mg for replicons, 10 mg for virus) was mixed with
400 ml cell suspension and electroporated at 270 V and 950 mF. Cells
were recovered in pre-warmed medium and seeded as required.
Colony formation assays were performed as described previously
(McCormick et al., 2004).
Luciferase assay. Cells were harvested by the addition of Passive
Lysis Buffer (Promega). Luciferase Assay Reagent (Promega) was
added (30 ml per 50 ml of cell lysate) and luminescence was measured
by using a BMG plate reader.
Antibodies. The polyclonal rabbit anti-NS2 serum, 4106, was raised
against purified, NS2 cytosolic domain (detailed protocols available
upon request). Sheep antisera against HCV non-structural proteins
NS3 and NS5A have been described previously (Aoubala et al., 2001;
Macdonald et al., 2003), rabbit anti-NS5A serum was provided by
Ralf Bartenschlager. Antibodies for cellular proteins were obtained
commercially and used as described by the manufacturers; mAbs to
calreticulin (Calbiochem), flotillin-1 (BD Biosciences), glyceralde-
hyde-3 phosphate dehydrogenase (GAPDH; Abcam), and polyclonal
sera to cytochrome c and histone H1 (Abcam). HRP- (Sigma) or
Alexa-Fluor (Invitrogen)-conjugated secondary antibodies were used
for Western blotting or immunofluorescence, respectively.
Cell fractionation. Cells were harvested, washed twice with PBS, then
lysed in GLB [1% TX-100, 120 mM KCl, 30 mM NaCl, 5 mM MgCl2,
10% glycerol (v/v) and 10 mM PIPES-NaOH, pH 7.2], supplemented
with Complete protease inhibitor cocktail (Roche), on ice for 15 min.
Insoluble material was pelleted by centrifugation at 500 g for 5 min at
4 uC. Lysates were clarified by a second centrifugation at 500 g, and the
pellets were washed twice in GLB. Normalized lysate and pellet
fractions were analysed by Western blotting.
Immunoprecipitation. Cells were harvested and lysed in IP buffer
[20 mM Tris/HCl pH 7.4, 135 mM NaCl, 1% TX-100, 0.5% sodium
deoxycholate and 10% glycerol (v/v)], supplemented with Complete
protease inhibitor cocktail (Roche). Lysates were diluted to 2 mg total
protein ml21 then 500 mg protein was mixed with 2 ml antiserum at
4 uC. Following overnight incubation, 25 ml magnetic protein G beads
(New England Biolabs) were added and the samples incubated for 4 h
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at 4 uC. Beads were washed three times in IP buffer then eluted by
boiling in 26 Laemmli buffer for 5 min.
Indirect immunofluorescence microscopy. Cells, seeded onto
coverslips 24 h prior to fixation, were washed twice with PBS then fixed
with 4% paraformaldehyde for 10 min at room temperature. Following
washing, cells were permeabilized with 0.2% TX-100 in PBS for a
further 10 min, washed twice with PBS, then incubated with primary
antibody diluted in PBS/10% FBS in for 1 h at room temperature. The
coverslips were washed with PBS/10% FBS then incubated with Alexa-
Fluor-conjugated secondary antibody. The coverslips were then stained
with a second primary antibody, if required, by the same method.
Before mounting onto slides, the coverslips were incubated with
Hoechst 33342 (Molecular Probes) diluted 1 : 10 000 in PBS for 5 min
to stain nuclei, then washed twice in PBS. Coverslips were mounted
with Citifluor AF1 (Agar Scientific). Images were captured using an
Olympus IX71 microscope with a6100 oil immersion objective with a
numerical aperture of 1.35 (DeltaVision – Applied Precision). Z-stacks
were collected comprising optical slices of 0.2 mm and deconvolved by
using Softworx software (Applied Precision).
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